Coenzyme Q10 for Gulf War Illness: A Replication Study

Last updated: November 15, 2024
Sponsor: University of California, San Diego
Overall Status: Active - Recruiting

Phase

3

Condition

Mitochondrial Diseases

Treatment

PharmaNord Bio-Quinone Active CoQ10 Gold 100mg

PharmaNord Placebo

Clinical Study ID

NCT06515184
GW190064
  • Ages > 50
  • All Genders

Study Summary

The purpose of this study is to assess whether a high quality preparation of ubiquinone (coenzyme Q10) benefits symptoms, function, and quality of life in veterans with Gulf War illness.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Meets both CDC and Kansas deployment and symptom inclusion criteria.

  • Does not have a disqualifying condition.

  • Able to travel to a local Quest facility for study blood draws.

  • Adequate internet access to allow ZoomPro visit participation and remote surveycompletion.

  • Health prior to the Gulf War rated as "very good" or "excellent" (to exclude personswho may have had other health conditions with different mechanisms as the cause oftheir symptoms).

  • Willing to defer initiation of discretionary treatments or supplements during theexpected course of study participation.

Exclusion

Exclusion Criteria:

  • Participating in another clinical trial.

  • Still-evolving adverse effects following another medication or health condition,such as covid or fluoroquinolone use.

  • On Coumadin/ warfarin.

  • Unable to participate for the required duration of the study.

Study Design

Total Participants: 192
Treatment Group(s): 2
Primary Treatment: PharmaNord Bio-Quinone Active CoQ10 Gold 100mg
Phase: 3
Study Start date:
September 13, 2024
Estimated Completion Date:
December 31, 2027

Connect with a study center

  • UC San Diego

    La Jolla, California 92093
    United States

    Active - Recruiting

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.